C

CNS Pharmaceuticals
D

CNSP

0.10400
USD
-0.01
(-12.24%)
Market Closed
Volume
114,291
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,343,226
OverviewSignalsIdeasNews
Related Instruments
    A
    ACRX
    0
    (0%)
    0.000000 USD
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ALT
    -0.27000
    (-4.24%)
    6.10000 USD
    S
    SLS
    0.08000
    (6.90%)
    1.24000 USD
    T
    TTNP
    -0.42000
    (-7.00%)
    5.58000 USD
    V
    VBIV
    -0.00920
    (-7.34%)
    0.11610 USD
    V
    VBLT
    -0.01140
    (-6.65%)
    0.16000 USD
    X
    XERS
    -0.05500
    (-2.21%)
    2.43000 USD
    More
News

Title: CNS Pharmaceuticals Inc

Sector: Healthcare
Industry: Biotechnology
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.